Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Rapid Micro Biosystems Q4 EPS $(0.22) Beats $(0.23) Estimate, Sales $8.22M Beat $7.80M Estimate

Author: Benzinga Newsdesk | February 28, 2025 06:37am
Rapid Micro Biosystems (NASDAQ:RPID) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.23) by 4.35 percent. This is a 15.38 percent increase over losses of $(0.26) per share from the same period last year. The company reported quarterly sales of $8.22 million which beat the analyst consensus estimate of $7.80 million by 5.36 percent. This is a 29.68 percent increase over sales of $6.34 million the same period last year.

Posted In: RPID


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist